SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 57.66+0.5%12:22 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (9615)12/1/2003 5:02:58 PM
From: Icebrg  Read Replies (1) of 52153
 
Another company high on the short list is ICOS with close to 11,4 % of the total shares outstanding being represented by short positions.

Among the notable sell-recommendations (i.e. in this case short recommendations) is Avalon Research's. They issued a sell recommendation about a year ago when the stock was trading at USD 25,50. Since then they have re-iterated this recommendation 6 times while the stock has seen its price increase by 20 dollars. With Cialis approved their chances to recover the losses seem minimal.

investars.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News